Bristol-Myers Squibb Company (JOBS) Could Walk Away from ImClone Systems Incorporated Says CFO

LONDON, Sept 16 (Reuters) - Bristol-Myers Squibb could abandon its bid for biotech company ImClone Systems in certain circumstances, the U.S. drugmaker's chief financial officer said on Tuesday.